DCGI
-
Mobile
Covid 19 vaccine की सबसे पहले इमरजेंसी इस्तेमाल की परमीशन मांगने वाली Pfizer ने अब ये क्यों किया?
तेरा तुझको अर्पण के लिए यहां क्लिक करें – Download the App:- Story: सबसे पहले कोरोना वैक्सीन की मंजूरी मांगने वाली फाइजर ने एप्लिकेशन वापस क्यों ले ली? – Pfizer Withdraws Emergency Use Request For Its Covid-19 Vaccine In India – thelallantop.com दुनियाभर में जब कोरोना की वैक्सीन के इमरजेंसी इस्तेमाल के लिए अप्रूवल के लिए लाइन लगी है वहीं…
Read More » -
Mobile
Covid-19 Vaccine Covishield Gets Approval From DCGI’s Expert Panel
Covishield, the vaccine candidate from Pune-based Serum Institute of India, was approved by a Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) late on Friday. Bharat Biotech has been asked to furnish more data demonstrating the efficacy of its candidate, Covaxin The nod for Covishield came at the end of a marathon meeting of the SEC…
Read More » -
Mobile
DCGI approves restricted emergency use of Covishield, Covaxin COVID-19 vaccines
ભારતમાં કોરોનાની આ બે વેક્સીનને મળી મંજૂરી, ટૂંક સમયમાં શરૂ થશે રસીકરણ Two vaccines of corona were approved for emergency use in the country. DCGI approves restricted emergency use of Covishield, Covaxin COVID-19 vaccines. The DCGI has also granted permission to Cadila Healthcare for conducting phase-III clinical trial of their COVID-19 vaccine candidate.DCGI VG Somani said both the drug firms…
Read More »